Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × Ribavirin × Clear all

NCT01056757 2015-11-04

Treatment With Ribavirin for Patients With Metastatic Breast Cancer

Phase 1/2 Terminated

Breast Neoplasms